<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0585">
 <element-citation publication-type="journal" id="sbref0585">
  <person-group person-group-type="author">
   <name>
    <surname>Gulick</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Fatkenheuer</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Burnside</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Hardy</surname>
    <given-names>W.D.</given-names>
   </name>
   <name>
    <surname>Nelson</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Goodrich</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mukwaya</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Portsmouth</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Heera</surname>
    <given-names>J.R.</given-names>
   </name>
  </person-group>
  <article-title>Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patients</article-title>
  <source>J. Acquir. Immune Defic. Syndr.</source>
  <volume>65</volume>
  <year>2014</year>
  <fpage>78</fpage>
  <lpage>81</lpage>
  <pub-id pub-id-type="doi">10.1097/QAI.0b013e3182a7a97a</pub-id>
  <pub-id pub-id-type="pmid">24419064</pub-id>
 </element-citation>
</ref>
